• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绘制帕金森病患者 UPDRS 和 PDQ-8 与 EQ-5D 指数的关系图。

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease.

机构信息

Department of Neurology, Philipps-University, Marburg, Germany.

出版信息

Health Qual Life Outcomes. 2013 Mar 8;11:35. doi: 10.1186/1477-7525-11-35.

DOI:10.1186/1477-7525-11-35
PMID:23497005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3662160/
Abstract

BACKGROUND

Clinical studies employ the Unified Parkinson's Disease Rating Scale (UPDRS) to measure the severity of Parkinson's disease. Evaluations often fail to consider the health-related quality of life (HrQoL) or apply disease-specific instruments. Health-economic studies normally use estimates of utilities to calculate quality-adjusted life years. We aimed to develop an estimation algorithm for EuroQol- 5 dimensions (EQ-5D)-based utilities from the clinical UPDRS or disease-specific HrQoL data in the absence of original utilities estimates.

METHODS

Linear and fractional polynomial regression analyses were performed with data from a study of Parkinson's disease patients (n=138) to predict the EQ-5D index values from UPDRS and Parkinson's disease questionnaire eight dimensions (PDQ-8) data. German and European weights were used to calculate the EQ-5D index. The models were compared by R(2), the root mean square error (RMS), the Bayesian information criterion, and Pregibon's link test. Three independent data sets validated the models.

RESULTS

The regression analyses resulted in a single best prediction model (R(2): 0.713 and 0.684, RMS: 0.139 and 13.78 for indices with German and European weights, respectively) consisting of UPDRS subscores II, III, IVa-c as predictors. When the PDQ-8 items were utilised as independent variables, the model resulted in an R2 of 0.60 and 0.67. The independent data confirmed the prediction models.

CONCLUSION

The best results were obtained from a model consisting of UPDRS subscores II, III, IVa-c. Although a good model fit was observed, primary EQ-5D data are always preferable. Further validation of the prediction algorithm within large, independent studies is necessary prior to its generalised use.

摘要

背景

临床研究采用统一帕金森病评定量表(UPDRS)来衡量帕金森病的严重程度。评估往往未能考虑到健康相关的生活质量(HrQoL)或应用特定于疾病的工具。健康经济学研究通常使用效用估计来计算质量调整生命年。我们旨在开发一种从临床 UPDRS 或特定于疾病的 HrQoL 数据中估算基于 EuroQol-5 维度(EQ-5D)的效用的估算算法,而无需原始效用估计。

方法

使用帕金森病患者研究(n=138)的数据进行线性和分数多项式回归分析,以预测 UPDRS 和帕金森病问卷 8 维度(PDQ-8)数据的 EQ-5D 指数值。使用德国和欧洲权重计算 EQ-5D 指数。通过 R(2)、均方根误差(RMS)、贝叶斯信息准则和 Pregibon 链接检验比较模型。三个独立的数据集验证了模型。

结果

回归分析得出了一个最佳的单一预测模型(R(2):分别为 0.713 和 0.684,RMS:分别为 0.139 和 13.78,用于德国和欧洲权重的指数),由 UPDRS 子量表 II、III、IVa-c 作为预测因子。当 PDQ-8 项目用作独立变量时,模型的 R2 为 0.60 和 0.67。独立数据证实了预测模型。

结论

最好的结果来自于由 UPDRS 子量表 II、III、IVa-c 组成的模型。虽然观察到模型拟合良好,但始终首选原始 EQ-5D 数据。在广泛的独立研究中进一步验证预测算法的有效性是必要的,然后才能广泛使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3183/3662160/54b9390ae743/1477-7525-11-35-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3183/3662160/54b9390ae743/1477-7525-11-35-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3183/3662160/54b9390ae743/1477-7525-11-35-1.jpg

相似文献

1
Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease.绘制帕金森病患者 UPDRS 和 PDQ-8 与 EQ-5D 指数的关系图。
Health Qual Life Outcomes. 2013 Mar 8;11:35. doi: 10.1186/1477-7525-11-35.
2
Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.MDS-UPDRS 各领域与帕金森病患者健康相关生活质量的关系。
Eur J Neurol. 2014 Mar;21(3):519-24. doi: 10.1111/ene.12349. Epub 2014 Jan 21.
3
Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.将 PDQ-39 评分映射到帕金森病患者的 EQ-5D 评分。
Qual Life Res. 2013 Jun;22(5):1065-72. doi: 10.1007/s11136-012-0231-6. Epub 2012 Jul 11.
4
Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.将帕金森特定评分转化为健康状态效用值,以评估成本效用分析。
Patient. 2018 Dec;11(6):665-675. doi: 10.1007/s40271-018-0317-5.
5
Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans.帕金森病患者的健康相关生活质量:美国男性退伍军人中健康效用指数 III 与统一帕金森病评定量表(UPDRS)的相关性。
Health Qual Life Outcomes. 2010 Aug 30;8:91. doi: 10.1186/1477-7525-8-91.
6
Convergent validation of EQ-5D-5L in patients with Parkinson's disease.帕金森病患者中EQ-5D-5L的收敛效度验证。
J Neurol Sci. 2015 Nov 15;358(1-2):53-7. doi: 10.1016/j.jns.2015.08.010. Epub 2015 Aug 7.
7
The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.EQ-5D(一种通用的生活质量衡量工具)是评估帕金森病患者生活质量的有效手段。
J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):67-73. doi: 10.1136/jnnp.69.1.67.
8
Parkinson's disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial.帕金森病伴早期运动并发症:早期刺激试验中从 PDQ-39 数据预测 EQ-5D-3L 效用值。
Health Qual Life Outcomes. 2020 Mar 2;18(1):49. doi: 10.1186/s12955-020-01299-y.
9
The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).帕金森病患者生活质量的关键决定因素:帕金森病生物标志物项目(PDBP)的结果。
J Parkinsons Dis. 2016 May 31;6(3):523-32. doi: 10.3233/JPD-160851.
10
Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.从帕金森病问卷PDQ - 39到通用欧洲生活质量量表EQ - 5D - 3L的映射:混合模型的价值
Med Decis Making. 2015 Oct;35(7):902-11. doi: 10.1177/0272989X15584921. Epub 2015 Apr 29.

引用本文的文献

1
Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis.用于远程连续监测帕金森病患者的设备:系统评价和成本效益分析。
Health Technol Assess. 2024 Jul;28(30):1-187. doi: 10.3310/YDSL3294.
2
A person-centered approach to characterizing longitudinal ambulatory impairment in Parkinson's disease.以患者为中心的方法来描述帕金森病的纵向日常活动障碍。
Sci Rep. 2024 May 20;14(1):11509. doi: 10.1038/s41598-024-62179-9.
3
Feasibility and effectiveness of a remote individual rehabilitation program for people with Parkinson's disease living in the Brazilian Amazon: a randomized clinical trial.

本文引用的文献

1
Markov blanket-based approach for learning multi-dimensional Bayesian network classifiers: an application to predict the European Quality of Life-5 Dimensions (EQ-5D) from the 39-item Parkinson's Disease Questionnaire (PDQ-39).基于马尔可夫毯的多维贝叶斯网络分类器学习方法:在预测欧洲生活质量-5 维度(EQ-5D)来自 39 项帕金森病问卷(PDQ-39)中的应用。
J Biomed Inform. 2012 Dec;45(6):1175-84. doi: 10.1016/j.jbi.2012.07.010. Epub 2012 Aug 8.
2
Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.预测美国样本中疾病预防控制中心“健康天数”与欧洲五维健康量表(EQ-5D)指数的关系。
Med Decis Making. 2011 Jan-Feb;31(1):174-85. doi: 10.1177/0272989X10364845. Epub 2010 Apr 7.
3
针对居住在巴西亚马逊地区的帕金森病患者的远程个体康复计划的可行性和有效性:一项随机临床试验。
Front Neurol. 2023 Aug 25;14:1244661. doi: 10.3389/fneur.2023.1244661. eCollection 2023.
4
Evaluation and validation of a patient-reported quality-of-life questionnaire for Parkinson's disease.帕金森病患者报告的生活质量问卷的评估与验证
J Patient Rep Outcomes. 2022 Mar 2;6(1):17. doi: 10.1186/s41687-022-00427-0.
5
Parkinson's disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial.帕金森病伴早期运动并发症:早期刺激试验中从 PDQ-39 数据预测 EQ-5D-3L 效用值。
Health Qual Life Outcomes. 2020 Mar 2;18(1):49. doi: 10.1186/s12955-020-01299-y.
6
Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.将帕金森特定评分转化为健康状态效用值,以评估成本效用分析。
Patient. 2018 Dec;11(6):665-675. doi: 10.1007/s40271-018-0317-5.
7
Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis.针对伴有早期运动并发症的帕金森病的脑深部电刺激:一项英国成本效益分析。
PLoS One. 2016 Jul 21;11(7):e0159340. doi: 10.1371/journal.pone.0159340. eCollection 2016.
8
Deep Brain Stimulation Can Preserve Working Status in Parkinson's Disease.深部脑刺激可维持帕金森病的工作状态。
Parkinsons Dis. 2015;2015:936865. doi: 10.1155/2015/936865. Epub 2015 Jul 30.
9
Combining fractional polynomial model building with multiple imputation.将分数多项式模型构建与多重填补相结合。
Stat Med. 2015 Nov 10;34(25):3298-317. doi: 10.1002/sim.6553. Epub 2015 Jun 10.
10
Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.对从生活质量或临床指标到 EQ-5D 的映射研究进行综述:一个在线数据库。
Health Qual Life Outcomes. 2013 Sep 5;11:151. doi: 10.1186/1477-7525-11-151.
Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index.
将八项帕金森病问卷(PDQ - 8)映射到EQ - 5D效用指数。
Qual Life Res. 2008 Nov;17(9):1173-81. doi: 10.1007/s11136-008-9392-8. Epub 2008 Sep 20.
4
Cost of illness and its predictors for Parkinson's disease in Germany.德国帕金森病的疾病成本及其预测因素。
Pharmacoeconomics. 2005;23(8):817-36. doi: 10.2165/00019053-200523080-00007.
5
Preference-based quality-of-life in patients with Parkinson's disease.帕金森病患者基于偏好的生活质量
Neurology. 2002 Jul 9;59(1):103-8. doi: 10.1212/wnl.59.1.103.
6
The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.EQ-5D(一种通用的生活质量衡量工具)是评估帕金森病患者生活质量的有效手段。
J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):67-73. doi: 10.1136/jnnp.69.1.67.
7
The use of fractional polynomials to model continuous risk variables in epidemiology.在流行病学中使用分数多项式对连续风险变量进行建模。
Int J Epidemiol. 1999 Oct;28(5):964-74. doi: 10.1093/ije/28.5.964.
8
EuroQol--a new facility for the measurement of health-related quality of life.欧洲生活质量量表——一种衡量健康相关生活质量的新工具。
Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.